Belviq wasn't going to get approved in Europe prior to the U.S. launch. A successful track record of sales and usage in the U.S. plus an European partner such as Sanofi will get Belviq approved.
This is still one press release away from $12.00.
Add a few shares before the launch.
"Patience is a virtue."
eu in 2015.